Mirae Asset Global ETFs Holdings
VYGR icon

Mirae Asset Global ETFs Holdings’s Voyager Therapeutics VYGR Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$84.7K Buy
24,209
+2,082
+9% +$7.9K ﹤0.01% 2902
2026
Q1 		$85.4K Buy
22,127
+541
+3% +$2.13K ﹤0.01% 2733
2025
Q4 		$84.8K Sell
21,586
-735
-3% -$3.25K ﹤0.01% 2743
2025
Q3 		$104K Sell
22,321
-4,026
-15% -$14.6K ﹤0.01% 2633
2025
Q2 		$81.9K Sell
26,347
-1,170
-4% -$3.77K ﹤0.01% 2705
2025
Q1 		$93K Buy
27,517
+1,170
+4% +$5.46K ﹤0.01% 2666
2024
Q4 		$149K Buy
26,347
+1,140
+5% +$7.35K ﹤0.01% 2537
2024
Q3 		$147K Buy
25,207
+2,323
+10% +$16.9K ﹤0.01% 2524
2024
Q2 		$181K Buy
+22,884
New +$192K ﹤0.01% 2306

Other funds holding VYGR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's VYGR Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings increased its Voyager Therapeutics (VYGR) stake by 9.4% in Q2 2026, buying an estimated $7.9K and bringing the position to 24,209 shares worth $84.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2902.

Mirae Asset Global ETFs Holdings first reported a position in VYGR in Q2 2024 and has held it in 9 quarters since. The position peaked at $181K in Q2 2024. 136 funds tracked by Wall St. Rank hold VYGR as of Q2 2026.

  • Mirae Asset Global ETFs Holdings held 24,209 shares of Voyager Therapeutics worth $84.7K as of Q2 2026.
  • Mirae Asset Global ETFs Holdings bought 2,082 Voyager Therapeutics shares in Q2 2026, an estimated $7.9K.
  • Voyager Therapeutics made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #2902 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Voyager Therapeutics in Q2 2024 and has held it in 9 quarters since.
  • Mirae Asset Global ETFs Holdings's Voyager Therapeutics position peaked at $181K in Q2 2024.
  • 136 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.